Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GoodRx Holdings, Inc.GDRX · Entity 4838 | President, Consumer | April 01, 2022 | April 06, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GoodRx Holdings, Inc.
Report date April 01, 2022 · Filed April 06, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 3,007,708 |
Ending reported balance
After 2022-04-01 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-04-01 · Exercise / conversion · Acquired 62,500 · Balance 3,038,696 F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Row 2 · 2022-04-01 · Tax withholding · Disposed 30,988 · Balance 3,007,708 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 625,000 |
Reported balance
After 2022-04-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-04-01 · Exercise / conversion · Disposed 62,500 · Balance 625,000 F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F3: On October 30, 2020, the reporting person was granted 1,000,000 restricted stock units, vesting in 16 equal quarterly installments commencing on October 1, 2020, subject to the reporting person's continued employment through each applicable vesting date. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy Trust | 197,418 |
Reported balance
Holding disclosure · report date 2022-04-01 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 197,418 F2: Shares held by The Arisa Slutsky Spousal Trust. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
F2: Shares held by The Arisa Slutsky Spousal Trust.
F3: On October 30, 2020, the reporting person was granted 1,000,000 restricted stock units, vesting in 16 equal quarterly installments commencing on October 1, 2020, subject to the reporting person's continued employment through each applicable vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 30, 2020 Filed Feb 12, 2021 21:15 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GiftClass A Common Stock | 247,418 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-006297 · doc5.xml · nonDerivative · entry 5 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,180,010 Read SEC document |
| December 30, 2020 Filed Feb 12, 2021 21:15 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GiftClass A Common Stock | 247,418 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-006297 · doc5.xml · nonDerivative · entry 4 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 247,418 F1 · ownership.nature: Shares held by The Arisa Slutsky Spousal Trust. Read SEC document |
| December 30, 2020 Filed Feb 12, 2021 21:15 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GiftClass A Common Stock | 247,418 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-006297 · doc5.xml · nonDerivative · entry 3 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Read SEC document |
| November 09, 2020 Filed Feb 12, 2021 21:15 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GiftClass A Common Stock | 247,418 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-006297 · doc5.xml · nonDerivative · entry 2 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 247,418 Read SEC document |
| November 09, 2020 Filed Feb 12, 2021 21:15 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GiftClass A Common Stock | 247,418 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-006297 · doc5.xml · nonDerivative · entry 1 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,427,428 Read SEC document |
| November 02, 2020 Filed Dec 15, 2020 21:15 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 3,556,557 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-033895 · doc4.xml · derivative · entry 2 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 3,556,557 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F1 · derivative.exercise_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. F1 · derivative.expiration_date: Each share of Class B common stock is convertible at any time at the option of the holder into one share of the Issuer's Class A common stock or upon the earliest to occur of (1) the first date on which the aggregate number of outstanding shares of Class B common stock ceases to represent at least 10% of the then-outstanding shares of common stock, (2) the transfer of such share of Class B common stock, other than certain permitted transfers, or (3) September 25, 2027. Read SEC document |
| November 02, 2020 Filed Dec 15, 2020 21:15 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass A Common Stock | 3,556,557 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-033895 · doc4.xml · nonDerivative · entry 1 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,639,828 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 30, 2020 Filed Nov 3, 2020 22:00 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantRestricted Stock Unit · Derivative | 1,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-030259 · doc4.xml · derivative · entry 1 Slutsky Andrew · CIK 0001822299 · President, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Class A Common Stock · 1,000,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. The restricted stock units vest in 16 equal quarterly installments commencing on October 1, 2020, subject to the reporting person's continued employment through each applicable vesting date. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. The restricted stock units vest in 16 equal quarterly installments commencing on October 1, 2020, subject to the reporting person's continued employment through each applicable vesting date. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. The restricted stock units vest in 16 equal quarterly installments commencing on October 1, 2020, subject to the reporting person's continued employment through each applicable vesting date. Read SEC document |
| September 25, 2020 Filed Sep 30, 2020 01:58 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass B Common Stock · Derivative | 218,868 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-026483 · doc4.xml · derivative · entry 3 Slutsky Andrew · CIK 0001822299 · President & Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,556,557 Underlying: Class A Common Stock · 218,868 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of the Issuer's Class A Common Stock. The Class B Common Stock will automatically convert into shares of the Issuer's Class A Common Stock on a one-to-one basis upon either (a) any transfer of the Class B Common Stock by the holder, whether or not for value, subject to certain exceptions or (b) the earliest to occur of (i) seven years from the filing and effectiveness of the Issuer's amended and restated certificate of incorporation and (ii) the voting power of the Issuer's outstanding Class B Common Stock representing less than 10% of the combined voing power of all of the Issuer's outstanding common stock. F1 · derivative.exercise_date: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of the Issuer's Class A Common Stock. The Class B Common Stock will automatically convert into shares of the Issuer's Class A Common Stock on a one-to-one basis upon either (a) any transfer of the Class B Common Stock by the holder, whether or not for value, subject to certain exceptions or (b) the earliest to occur of (i) seven years from the filing and effectiveness of the Issuer's amended and restated certificate of incorporation and (ii) the voting power of the Issuer's outstanding Class B Common Stock representing less than 10% of the combined voing power of all of the Issuer's outstanding common stock. F1 · derivative.expiration_date: Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of the Issuer's Class A Common Stock. The Class B Common Stock will automatically convert into shares of the Issuer's Class A Common Stock on a one-to-one basis upon either (a) any transfer of the Class B Common Stock by the holder, whether or not for value, subject to certain exceptions or (b) the earliest to occur of (i) seven years from the filing and effectiveness of the Issuer's amended and restated certificate of incorporation and (ii) the voting power of the Issuer's outstanding Class B Common Stock representing less than 10% of the combined voing power of all of the Issuer's outstanding common stock. Read SEC document |
| September 25, 2020 Filed Sep 30, 2020 01:58 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | SaleClass A Common Stock | 218,868 | $33.00 | $7,222,644.00 |
DisclosureSEC source: 0000899243-20-026483 · doc4.xml · nonDerivative · entry 2 Slutsky Andrew · CIK 0001822299 · President & Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,271 Read SEC document |
| September 25, 2020 Filed Sep 30, 2020 01:58 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | ConversionClass A Common Stock | 218,868 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-026483 · doc4.xml · nonDerivative · entry 1 Slutsky Andrew · CIK 0001822299 · President & Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 302,139 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.